Finance

Beta
Lists
300401:SHE
Zhejiang Garden Biopharmaceutical Co Ltd
CNÂ¥19.93
-4.41%
(-0.92) 1D
Jun 24, 3:04:25 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300401...
Open
CNÂ¥20.45
High
CNÂ¥20.85
Low
CNÂ¥19.17
Mkt. cap
10.80B
Avg. vol.
26.40M
Volume
70.12M
Dividend
0.57%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 27, 2026
P/E ratio
43.85
52-wk high
CNÂ¥20.85
52-wk low
CNÂ¥10.68
EPS
CNÂ¥0.45
Shares outstanding
543.76M
No. of employees
1K
Open
CNÂ¥20.45
High
CNÂ¥20.85
Low
CNÂ¥19.17
Mkt. cap
10.80B
Avg. vol.
26.40M
Volume
70.12M
Dividend
0.57%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 27, 2026
P/E ratio
43.85
52-wk high
CNÂ¥20.85
52-wk low
CNÂ¥10.68
EPS
CNÂ¥0.45
Shares outstanding
543.76M
No. of employees
1K
News stories
From sources across the web
About Zhejiang Garden Biopharmaceutical Co Ltd
CEO-
Employees1.16K
FoundedDec 18, 2000
Headquarters-
SectorPharmaceutical industry
Websitehybiotech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
308.97M
300.34M
301.70M
276.88M
Cost of goods sold
141.31M
136.43M
137.15M
141.57M
Cost of revenue
141.31M
136.43M
137.15M
141.57M
Research and development expenses
16.55M
14.31M
18.22M
23.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
70.04M
55.41M
49.66M
45.59M
Operating expense
97.04M
62.68M
84.79M
68.58M
Total operating expenses
238.35M
199.12M
221.94M
210.15M
Operating income
70.62M
101.22M
79.76M
66.73M
Other non operating income
-7.96M
1.64M
-2.14M
-7.93M
EBT including unusual items
73.63M
83.45M
83.67M
56.91M
EBT excluding unusual items
60.66M
94.32M
69.46M
54.19M
Income tax expense
8.59M
10.94M
12.87M
6.64M
Effective tax rate
11.67%
13.11%
15.38%
11.68%
Other operating expenses
10.35M
-8.31M
17.15M
2.77M
Net income
65.04M
72.51M
70.81M
50.27M
Net profit margin
21.05%
24.14%
23.47%
18.16%
Earnings per share
-
-
-
-
Interest and investment income
2.32M
2.73M
2.73M
2.74M
Interest expense
-7.27M
-8.32M
-8.97M
-7.35M
Net interest expenses
-4.95M
-5.60M
-6.24M
-4.61M
Depreciation and amortization charges
-
-
-
-
EBITDA
114.41M
140.10M
124.28M
111.26M
Gain or loss from assets sale
-159.00
159.00
2.24M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer